Audrey Lazenby

Title: Audrey Lazenby: Innovator in Immunotherapy

Introduction

Audrey Lazenby is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of immunotherapy, focusing on methods that enhance the immune response against tumors and pathogens. With a total of 2 patents, her work is paving the way for innovative treatments in medicine.

Latest Patents

Lazenby's latest patents include a method for the controlled release of pharmaceutically active substances for immunotherapy. This method describes how to stimulate a systemic immune response to tumor cells or antigens associated with pathogens. By administering a mixture of a controlled release vehicle containing an immunopotentiating agent and antigen, her invention provides sustained release of therapeutic compounds. This allows the host immune system to effectively combat both local and metastatic tumors. The immunopotentiating agents she utilizes typically include cytokines such as tumor necrosis factor, GM-CSF, interleukin, or interferon.

Career Highlights

Audrey Lazenby is affiliated with Johns Hopkins University, where she continues her research and development in immunotherapy. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in cancer treatment.

Collaborations

Some of her notable coworkers include Drew M Pardoll and Kam W Leong, who collaborate with her on various research projects aimed at improving immunotherapeutic strategies.

Conclusion

Audrey Lazenby is a trailblazer in the field of immunotherapy, with her patents reflecting her commitment to enhancing immune responses against cancer. Her work at Johns Hopkins University continues to inspire advancements in medical science.